302 related articles for article (PubMed ID: 23602765)
1. Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme.
Lu TT; Onizawa M; Hammer GE; Turer EE; Yin Q; Damko E; Agelidis A; Shifrin N; Advincula R; Barrera J; Malynn BA; Wu H; Ma A
Immunity; 2013 May; 38(5):896-905. PubMed ID: 23602765
[TBL] [Abstract][Full Text] [Related]
2. A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.
Enesa K; Moll HP; Luong L; Ferran C; Evans PC
FASEB J; 2015 May; 29(5):1869-78. PubMed ID: 25667218
[TBL] [Abstract][Full Text] [Related]
3. Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation.
Razani B; Whang MI; Kim FS; Nakamura MC; Sun X; Advincula R; Turnbaugh JA; Pendse M; Tanbun P; Achacoso P; Turnbaugh PJ; Malynn BA; Ma A
Nat Immunol; 2020 Apr; 21(4):422-433. PubMed ID: 32205880
[TBL] [Abstract][Full Text] [Related]
4. The seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosis.
Yamaguchi N; Yamaguchi N
FEBS Lett; 2015 May; 589(12):1369-75. PubMed ID: 25911380
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis.
Onizawa M; Oshima S; Schulze-Topphoff U; Oses-Prieto JA; Lu T; Tavares R; Prodhomme T; Duong B; Whang MI; Advincula R; Agelidis A; Barrera J; Wu H; Burlingame A; Malynn BA; Zamvil SS; Ma A
Nat Immunol; 2015 Jun; 16(6):618-27. PubMed ID: 25939025
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.
Shembade N; Ma A; Harhaj EW
Science; 2010 Feb; 327(5969):1135-9. PubMed ID: 20185725
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation.
Wertz IE; Newton K; Seshasayee D; Kusam S; Lam C; Zhang J; Popovych N; Helgason E; Schoeffler A; Jeet S; Ramamoorthi N; Kategaya L; Newman RJ; Horikawa K; Dugger D; Sandoval W; Mukund S; Zindal A; Martin F; Quan C; Tom J; Fairbrother WJ; Townsend M; Warming S; DeVoss J; Liu J; Dueber E; Caplazi P; Lee WP; Goodnow CC; Balazs M; Yu K; Kolumam G; Dixit VM
Nature; 2015 Dec; 528(7582):370-5. PubMed ID: 26649818
[TBL] [Abstract][Full Text] [Related]
8. A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals.
da Silva CG; Studer P; Skroch M; Mahiou J; Minussi DC; Peterson CR; Wilson SW; Patel VI; Ma A; Csizmadia E; Ferran C
Hepatology; 2013 May; 57(5):2014-25. PubMed ID: 23238769
[TBL] [Abstract][Full Text] [Related]
9. A20 restricts wnt signaling in intestinal epithelial cells and suppresses colon carcinogenesis.
Shao L; Oshima S; Duong B; Advincula R; Barrera J; Malynn BA; Ma A
PLoS One; 2013; 8(5):e62223. PubMed ID: 23671587
[TBL] [Abstract][Full Text] [Related]
10. Direct, noncatalytic mechanism of IKK inhibition by A20.
Skaug B; Chen J; Du F; He J; Ma A; Chen ZJ
Mol Cell; 2011 Nov; 44(4):559-71. PubMed ID: 22099304
[TBL] [Abstract][Full Text] [Related]
11. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
Wertz IE; O'Rourke KM; Zhou H; Eby M; Aravind L; Seshagiri S; Wu P; Wiesmann C; Baker R; Boone DL; Ma A; Koonin EV; Dixit VM
Nature; 2004 Aug; 430(7000):694-9. PubMed ID: 15258597
[TBL] [Abstract][Full Text] [Related]
12. A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.
Bellail AC; Olson JJ; Yang X; Chen ZJ; Hao C
Cancer Discov; 2012 Feb; 2(2):140-55. PubMed ID: 22585859
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.
Tavares RM; Turer EE; Liu CL; Advincula R; Scapini P; Rhee L; Barrera J; Lowell CA; Utz PJ; Malynn BA; Ma A
Immunity; 2010 Aug; 33(2):181-91. PubMed ID: 20705491
[TBL] [Abstract][Full Text] [Related]
14. Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6.
Jung SM; Lee JH; Park J; Oh YS; Lee SK; Park JS; Lee YS; Kim JH; Lee JY; Bae YS; Koo SH; Kim SJ; Park SH
Nat Commun; 2013; 4():2562. PubMed ID: 24096742
[TBL] [Abstract][Full Text] [Related]
15. An anti-inflammatory role of A20 zinc finger protein during trauma combined with endotoxin challenge.
Liu B; Jiang D; Ou Y; Hu Z; Jiang J; Lei X
J Surg Res; 2013 Dec; 185(2):717-25. PubMed ID: 24055365
[TBL] [Abstract][Full Text] [Related]
16. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
[TBL] [Abstract][Full Text] [Related]
17. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis.
Hammer GE; Turer EE; Taylor KE; Fang CJ; Advincula R; Oshima S; Barrera J; Huang EJ; Hou B; Malynn BA; Reizis B; DeFranco A; Criswell LA; Nakamura MC; Ma A
Nat Immunol; 2011 Oct; 12(12):1184-93. PubMed ID: 22019834
[TBL] [Abstract][Full Text] [Related]
18. The deubiquitinase activity of A20 is dispensable for NF-κB signaling.
De A; Dainichi T; Rathinam CV; Ghosh S
EMBO Rep; 2014 Jul; 15(7):775-83. PubMed ID: 24878851
[TBL] [Abstract][Full Text] [Related]
19. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.
Tokunaga F; Nishimasu H; Ishitani R; Goto E; Noguchi T; Mio K; Kamei K; Ma A; Iwai K; Nureki O
EMBO J; 2012 Oct; 31(19):3856-70. PubMed ID: 23032187
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
